PUR118
Sponsors
Pulmatrix Inc.
Conditions
Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis
Phase 1
Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118
CompletedNCT01333904
Start: 2011-02-28End: 2012-06-30Updated: 2012-09-07
A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis
CompletedNCT01543191
Start: 2012-02-29End: 2012-12-31Updated: 2013-07-19
Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers
CompletedNCT01690949
Start: 2012-08-31End: 2013-04-30Updated: 2013-07-19